Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Status:
Terminated
Trial end date:
2017-02-03
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen
(CXL) as a method to increase the biomechanical and biochemical stability of the cornea by
inducing additional cross-links within or between collagen fibers using UVA light and the
photo- mediator riboflavin. The purpose of this study is to generate data for presentation at
medical meetings and for peer-review publication